Sirnaomics Ltd. (HKG:2257)
Hong Kong
· Delayed Price · Currency is HKD 6.74
+0.27 (4.17%)
At close: Mar 10, 2026
Sirnaomics Revenue
Sirnaomics had revenue of $81.00K USD in the half year ending June 30, 2025, a decrease of -64.63%. This brings the company's revenue in the last twelve months to $949.00K, up 39.35% year-over-year. In the year 2024, Sirnaomics had annual revenue of $1.78M.
Revenue (ttm)
$949.00K
Revenue Growth
+39.35%
P/S Ratio
98.53
Revenue / Employee
$18.25K
Employees
52
Market Cap
733.98M HKD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Uni-Bio Science Group | 589.59M |
| JW (Cayman) Therapeutics Co. | 194.77M |
| 3D Medicines | 491.34M |
| Sunho Biologics | 18.63K |
| Brii Biosciences | 31.53M |
| Transcenta Holding | 10.31M |
| Wuhan YZY Biopharma | 163.65M |
| Beijing Biostar Pharmaceuticals | 58.66M |
Sirnaomics News
- 6 months ago - Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Benzinga